Pathophysiology - Synuclein's Surprise Party
- Core Pathology: An α-synucleinopathy where misfolded α-synuclein protein aggregates, disrupting neuronal function.
- Key Structures: These aggregates form two main structures:
- Lewy Bodies: Eosinophilic, spherical intracytoplasmic inclusions found primarily in cortical and subcortical neurons.
- Lewy Neurites: Damaged neuronal processes (axons, dendrites) containing α-synuclein.

⭐ Exam Favorite: The key distinction from Parkinson's disease is the location; in LBD, Lewy bodies are widespread in the cerebral cortex, leading to early cognitive symptoms.
Clinical Features - The Waxing & Waning
- Fluctuating Cognition: Core feature with significant variations in attention and alertness. Patients have "good days and bad days," with episodes of staring, lethargy, or disorganized speech.
- Visual Hallucinations: Recurrent, well-formed, and detailed visions (e.g., small animals, people).
- Spontaneous Parkinsonism: Cardinal features (bradykinesia, tremor, rigidity) develop.
- REM Sleep Behavior Disorder (RBD): Patients physically act out their dreams. Can predate cognitive decline by years.
- Severe Neuroleptic Sensitivity: Using antipsychotics can cause severe parkinsonism, confusion, and autonomic dysfunction.
⭐ The 1-Year Rule: For LBD, parkinsonism must develop within 1 year of cognitive decline. If cognitive impairment begins >1 year after motor symptoms, it's Parkinson's Disease Dementia (PDD).
📌 Mnemonic: LBD → Lethargic-Bradykinetic-Dazed (fluctuations, parkinsonism, cognitive impairment).
Diagnosis - Spotting the Signs
- Central Feature: Progressive dementia that impairs daily life.
- Core Clinical Features (≥2 for probable LBD):
- Fluctuating cognition, attention, & alertness.
- Recurrent, detailed visual hallucinations.
- REM Sleep Behavior Disorder (RBD).
- Spontaneous parkinsonism.
- 📌 The 1-Year Rule: Dementia must develop before or within 1 year of parkinsonian motor signs. If motor symptoms precede cognitive decline by >1 year, diagnose Parkinson's Disease Dementia.
⭐ Severe sensitivity to antipsychotic (neuroleptic) medications is a classic supportive feature, often leading to worsened parkinsonism and cognitive function.

Management - The Careful Balancing Act
- Cognitive Symptoms: Cholinesterase inhibitors (e.g., Rivastigmine, Donepezil) are first-line.
- Motor Symptoms (Parkinsonism):
- Use Carbidopa-Levodopa with caution and at the lowest effective dose.
- Monitor closely as it can worsen psychosis.
- Psychosis (Visual Hallucinations):
- Consider low-potency atypical antipsychotics like Quetiapine or Pimavanserin.
- ⚠️ AVOID: Typical antipsychotics (e.g., Haloperidol) and high-potency atypicals (e.g., Risperidone).
⭐ Neuroleptic Sensitivity: Up to 50% of LBD patients experience severe, potentially irreversible adverse reactions to antipsychotic medications, including worsening cognition, sedation, and parkinsonism.
High‑Yield Points - ⚡ Biggest Takeaways
- Core features are fluctuating cognition, recurrent visual hallucinations, and spontaneous parkinsonism.
- Dementia develops before or within 1 year of parkinsonian symptoms, distinguishing it from Parkinson's disease dementia.
- Visual hallucinations are typically well-formed and detailed.
- Pathophysiology involves α-synuclein aggregates (Lewy bodies) in the cortex.
- Patients have extreme sensitivity to antipsychotics, which can severely worsen symptoms.
- REM sleep behavior disorder is a common supportive feature.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app